Cargando…
Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras
PURPOSE: To quantify outcomes for neonatal retinoblastoma patients treated during the pre-chemotherapy (1980–1994) and chemotherapy (1995–2018) eras. METHODS: Retrospective review of retinoblastoma patients diagnosed within the first 28 days of life between 1/1/1980 and 11/30/2018. Student's t-...
Autores principales: | Camp, David A, Dalvin, Lauren A, Schwendeman, Rachel, Lim, Li-Anne S, Shields, Carol L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896534/ https://www.ncbi.nlm.nih.gov/pubmed/31755437 http://dx.doi.org/10.4103/ijo.IJO_634_19 |
Ejemplares similares
-
The role of intravitreal chemotherapy for retinoblastoma
por: Manjandavida, Fairooz P, et al.
Publicado: (2015) -
Modern treatment of retinoblastoma: A 2020 review
por: Ancona-Lezama, David, et al.
Publicado: (2020) -
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras
por: Selzer, Evan B, et al.
Publicado: (2019) -
Retinoblastoma: Achieving new standards with methods of chemotherapy
por: Kaliki, Swathi, et al.
Publicado: (2015) -
Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye
por: Su, Grace L., et al.
Publicado: (2019)